***Background.*** Central nervous system (CNS) tuberculosis (TB) can result in severe disability in children. We aimed to describe the clinical characteristics and post-treatment outcomes of pediatric CNS TB cases in California.

***Methods.*** All pediatric (aged ≤ 18 years) patients with CNS TB reported to the TB registry during 2001-2011 were included. We systematically abstracted information about clinical characteristics and outcomes within 1 year after treatment completion from local public health records, hospital admission records and outpatient follow-up records. Outcomes were categorized into good or poor on the basis of disability in hearing, vision, language, ambulation, development or focal neurologic deficits. Modified Medical Research Council (MRC) Score was used to classify severity of disease at presentation. We report preliminary findings from records abstracted to date.

***Results.*** Of 94 pediatric CNS TB cases reported, 45 cases were abstracted to date. Of those, 86.7% were 0-4 years old, 97.8% were U.S.-born and 73.3% were Hispanic. Fever (91.1%), vomiting (73.3%) and altered mental status (60%) were the most common symptoms at presentation. Tuberculin skin test was positive in 51.1% of cases tested. MRC score classified cases into Stage I (18.6%), Stage II (53.5%) and Stage III (27.9%). A positive *M. tuberculosis* culture was identified in 75.6% of the patients. Mono pyrazinamide resistance was seen in 17.6% of culture positive cases. Patients had poor post-treatment outcomes (62.2%) including moderate clinical sequelae (28.6%), severe clinical sequelae (60.7%) and death (10.7%). In unadjusted analysis, children aged 0-4 years and those with Stage III MRC Score were more likely to have poor outcomes.

***Conclusion.*** The majority of pediatric CNS TB cases reviewed have poor post-treatment outcomes, with younger age and advanced disease at presentation associated with poor outcomes. Interventions to improve outcomes and prevent CNS TB in young children are needed.
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